Maria Luisa Navacchia

14PUBLICATIONS
26CO-AUTHORS
Biologically active moleculesBiomolecular modelling and designGlycoconjugatesHaematological tumoursWater treatment processes
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 28, 2026
Biological Evaluation and SAR Exploration of Bile Acid-Dihydroartemisinin Hybrids as Potential Anticancer Agents for Colorectal Cancer.

Daniela Perrone, Elisabetta Melloni, Lorenzo Gnudi

|Nov 27, 2024
Insights into SARS-CoV-2: Small-Molecule Hybrids for COVID-19 Treatment.

Maria Luisa Navacchia, Caterina Cinti, Elena Marchesi

|Jul 27, 2024
Evaluation of Anticancer Activity of Nucleoside-Nitric Oxide Photo-Donor Hybrids.

Elena Marchesi, Elisabetta Melloni, Fabio Casciano

|Dec 04, 2023
Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2.

Elena Marchesi, Valentina Gentili, Daria Bortolotti

|Sep 28, 2023
Molecular Hybridization as a Strategy for Developing Artemisinin-Derived Anticancer Candidates.

Elena Marchesi, Daniela Perrone, Maria Luisa Navacchia

|Mar 11, 2023
Anticancer Activity and Molecular Mechanisms of an Ursodeoxycholic Acid Methyl Ester-Dihydroartemisinin Hybrid via a Triazole Linkage in Hepatocellular Carcinoma Cells.

Ya-Fen Hsu, Fan-Lu Kung, Tzu-En Huang

Pageof 3

Frequent Collaborators

9 joint publications

Daniela Perrone

7 joint publications

Elena Marchesi

3 joint publications

Elisabetta Melloni

3 joint publications

Fabio Casciano